Wiskott-Aldrich syndrome: a retrospective study of 577 patients defines the genotype as a predictive biomarker for disease severity and survival

•The type of genetic variant is a predictive biomarker for disease severity and survival in WAS.•Patients with less severe variants experience a later onset of disease-related complications but remain prone to morbidity and premature mortality.